Latest Bayer News & Updates

See the latest news and media coverage for Bayer. We track all announcements, press releases, and industry mentions in real time, all in one place.

Bayer

Life science company in healthcare and agriculture

bayer.com

Headquarters: Leverkusen, Germany
Company type: Public company
Number of employees: 95,000+
Industry: Pharmaceuticals

Last updated Today

Latest news about Bayer

In short: Bayer reported improved second-quarter earnings, secured a €3 billion investment from Apollo, and advanced several key drug treatments.

Company announcements

Yesterday Bayer

Bayer launches Crop Science blockbusters and advances pipeline

The company introduces new seed traits and crop protection products globally. Bayer also reports cost reductions under its Five-Year Framework and highlights AI-driven R&D progress.

Yesterday Bayer

Bayer warns candidates against recruitment scammers impersonating recruiters

The company advises verifying email addresses and never sharing money or personal details with fake recruiters using suspicious domains.

September 9 Bayer

Bayer initiates Phase II study of GIRK4 inhibitor for atrial fibrillation

The investigational drug BAY 3670549 targets cardiomyocyte electrical activity based on positive Phase I data. It results from a research alliance with the Broad Institute.

September 2 Bayer

Bayer advances its agricultural pipeline and launches new products

The company implements a five-year strategic framework targeting mid-decade profitability while utilizing AI-driven breeding platforms to develop traits for key global markets.

Media coverage

Today Yahoo Finance

Apollo Funds Complete €3 Billion Capital Solution for Bayer

KKR joins Apollo as a minority participantNEW YORK and LEVERKUSEN, Germany, Sept. (GLOBE NEWSWIRE) -- Apollo (NYSE: APO) today announced that Apollo-managed funds and affiliates...

September 9 Yahoo Finance

Bayer Secures FDA Nod for Sevabertinib's First-Line Use in NSCLC

BAYRY's sevabertinib wins first-line NSCLC approval. The company advances BAY 3670549 into a phase II AFib study.

September 9 STAT

FDA expands Bayer lung cancer drug approval

UniQure readout tests durability of benefits, an AI effort to manage heart failure, and more biotech news from The Readout...

September 8 Fierce Biotech

Roivant’s $14M bet on Bayer’s inhaled hypertension med pays off with phase 2 win

Roivant’s $14 million bet on a pulmonary hypertension drug from Bayer appears to have paid off as th...

Never miss news about Bayer

Track Bayer and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Bayer competitors & trending companies

Browse news for competitors to Bayer and other trending companies.